Preview |
PDF (Original Artilce)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
6MB |
Other (Supplementary Information)
38MB |
Item Type: | Article |
---|---|
Title: | Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma |
Creators Name: | Briest, F., Noerenberg, D., Hennch, C., Yoshida, K., Hablesreiter, R., Nimo, J., Sasca, D., Kirchner, M., Mansouri, L., Inoue, Y., Wiegand, L., Staiger, A.M., Casadei, B., Korkolopoulou, P., Weiner, J., Lopez-Guillermo, A., Warth, A., Schneider, T., Nagy, Á., Klapper, W., Hummel, M., Kanellis, G., Anagnostopoulos, I., Mertins, P., Bullinger, L., Rosenquist, R., Vassilakopoulos, T.P., Ott, G., Ogawa, S. and Damm, F. |
Abstract: | Recent exome-wide studies discovered frequent somatic mutations in the epigenetic modifier ZNF217 in primary mediastinal B cell lymphoma (PMBCL) and related disorders. As functional consequences of ZNF217 alterations remain unknown, we comprehensively evaluated their impact in PMBCL. Targeted sequencing identified genetic lesions affecting ZNF217 in 33% of 157 PMBCL patients. Subsequent gene expression profiling (n = 120) revealed changes in cytokine and interferon signal transduction in ZNF217-aberrant PMBCL cases. In vitro, knockout of ZNF217 led to changes in chromatin accessibility interfering with binding motifs for crucial lymphoma-associated transcription factors. This led to disturbed expression of interferon-responsive and inflammation-associated genes, altered cell behavior, and aberrant differentiation. Mass spectrometry demonstrates that ZNF217 acts within a histone modifier complex containing LSD1, CoREST and HDAC and interferes with H3K4 methylation and H3K27 acetylation. Concluding, our data suggest non-catalytic activity of ZNF217, which directs histone modifier complex function and controls B cell differentiation-associated patterns of chromatin structure. |
Keywords: | B-Cell Lymphoma, Chromatin, Histones, Interferons, Mutation, Signal Transduction, Trans-Activators, Tumor Cell Line |
Source: | Leukemia |
ISSN: | 0887-6924 |
Publisher: | Nature Publishing Group |
Volume: | 37 |
Number: | 11 |
Page Range: | 2237-2249 |
Date: | November 2023 |
Official Publication: | https://doi.org/10.1038/s41375-023-02013-9 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page